Related Experiment Videos
Flurbiprofen in rheumatoid arthritis therapy
Current Medical Research and Opinion
|January 1, 1977
Summary
Flurbiprofen effectively treats rheumatoid arthritis symptoms and is better tolerated than indomethacin. It modifies inflammation in rats but cannot prevent immunological inflammation.
Area of Science:
- Pharmacology
- Rheumatology
- Immunology
Background:
- Rheumatoid arthritis (RA) is a chronic inflammatory disorder.
- Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for RA symptom management.
Purpose of the Study:
- To evaluate the efficacy and tolerability of flurbiprofen in rheumatoid arthritis patients.
- To assess the anti-inflammatory activity of flurbiprofen in an experimental rat model.
Main Methods:
- Open study: 24 patients received 300 mg flurbiprofen daily.
- Double-blind crossover study: 30 patients compared 300 mg flurbiprofen daily vs. 150 mg indomethacin daily.
- Rat model used to assess anti-inflammatory effects.
Main Results:
- Flurbiprofen demonstrated effectiveness in relieving rheumatoid arthritis symptoms.
- Flurbiprofen was better tolerated compared to indomethacin.
- In rats, flurbiprofen modified cellular infiltration in inflammation but did not prevent immunological inflammation.
Conclusions:
- Flurbiprofen is an effective and well-tolerated NSAID for rheumatoid arthritis treatment.
- Flurbiprofen exhibits anti-inflammatory properties, modulating cellular responses.
- Further research may explore flurbiprofen's specific mechanisms in inflammatory conditions.